U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07190404) titled 'Multicontext Approach for Cognitive Function in Parkinson Disease' on Sept. 09.
Brief Summary: Mild cognitive decline is common in early Parkinson disease (PD) and is associated with disability, reduced quality of life (QOL), and increased risk for dementia. Medical treatments for PD do not prevent or treat cognitive decline and may even exacerbate the problem.
Unfortunately, existing cognitive interventions for PD, which focus on restoring deficient cognitive skills through cognitive training (repetitive practice of tasks that challenge specific cognitive skills), provide limited benefit for daily function and QOL. To overcome th...